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Abstract 
Background: Accurate prognostic tools are determinant for decision-making in cancer 
care planning. Objective measures such as bioelectrical impedance spectroscopy (BIS) 
may improve the accuracy of prognostic. In this cross-sectional study the goal was to 
determine if the water compartments and the phase angle were predictors of muscular 
strength in breast cancer survivors (BCS).  
Methods: A total of 41 BCS (age 54.6 ± 9.2) were evaluated. Water compartments and 
phase angle were assessed with BIS and muscular strength was assessed with handgrip 
dynamometer. Moderate-to-vigorous physical activity (MVPA) was assessed using the 
International Physical Activity Questionnaire (IPAQ). Measurements were performed 
in the morning after an overnight feast.  
Results: Linear regression analysis showed that phase angle explained 22% (r2 = 0.216) 
of the variance of the handgrip. Independently of MVPA and time post-operation, phase 
angle remained a significant predictor (B=2.269, p=0.085). No associations were found 
between water compartments and handgrip strength (p>0.05).  
Conclusions: The findings of this study suggest that phase angle is an important 
predictor of muscular strength in breast cancer survivors. 
Key words: breast cancer, phase angle, muscular strength, water compartments, 
bioelectrical impedance spectroscopy, extracellular water, intracellular water, 





Introdução: É necessário definir medidas de prognóstico precisas para que haja uma 
melhor tomada de decisão relativamente ao planeamento do tratamento de cancro da 
mama. Medidas objetivas como a bioimpedância elétrica multiespectral (BIS) podem 
melhorar a precisão de prognóstico. Neste estudo transversal o objetivo será determinar 
se os compartimentos hídricos e o ângulo de fase são preditores da força muscular em 
sobreviventes de cancro da mama. 
Métodos: A amostra consistiu em 41 sobreviventes de cancro da mama (idade 54.6 ± 
9.2 anos). Os compartimentos hídricos e o ângulo de fase foram medidos com a BIS e 
a força muscular com um dinamómetro. A atividade física moderada a vigorosa 
(MVPA) foi avaliada através do Questionário Internacional de Atividade Física 
(IPAQ). As medições foram realizadas durante a manhã com os participantes em jejum. 
Resultados: A análise da regressão linear mostra que o ângulo de fase explica 22% (r2 
= 0.216) da variação da força muscular. Independentemente da MVPA e tempo pós-
operatório, o ângulo de fase manteve-se um preditor significativo (B=2.269, p=0.085). 
Não foram encontradas associações entre os compartimentos hídricos e força muscular 
(p>0.05). 
Conclusão: Os resultados deste estudo sugerem que o ângulo de fase é um importante 
preditor da força muscular em sobreviventes de cancro da mama.  
Palavras-chave: cancro da mama, ângulo de fase, força muscular, compartimentos 
hídricos, bioimpedância elétrica multiespectral, água extracelular, água 




Humans and animals have had cancer throughout recorded history. Some of the 
earliest evidence of cancer was found in ancient Egyptian manuscripts describing cases 
of tumor, or ulcers, of the breast that were removed by cauterization that date back to 
3000BC. At this time, they were describing this disease as not treatable.1 
Cancer is a term used for cells that start to grow out of control in a certain part of 
the body, because of damaged DNA. These cells are different from normal cells, instead 
of dying or repair the damage, they continue to grow and form new abnormal cells that 
the body does not need. Most DNA damage is caused by mistakes that happen while 
the normal cell is reproducing or by something in our environment.2  Cancer cells can 
also invade other tissues, throughout the bloodstream or lymph vessels of our body, 
where they begin to grow and form new tumors that replace normal tissue. This is a 
process called metastasis.2  
Breast cancer (BC) is the most common cancer among women in developed 
countries.3 In recent years, the BC incidence rates have been increasing throughout the 
world.3 With respect to Portugal, data from the report of the International Agency for 
Research on Cancer (IARC) from 20124 show that the number of new cancer cases per 
year (incidence) was 49,200 and the number who died (mortality) was 24,100. In terms 
of incidence and mortality, colorectal cancer is both the leading cause of cancer in our 
country, with 7,129 new cases diagnosed per year, as well as the leading cause of cancer 
mortality, with 3,797 reported deaths. This is followed by prostate cancer with 6,622 
incident cases and 1,582 deaths and breast cancer with respectively 6,088 (incident 
cases) and 1,570 (deaths).  
 In Portugal, BC ranks in first among cancers affecting women, with an age-
standardized incidence rate of 60.0/100 000 females.3 Due to early detection and more 
advanced treatment options, the mortality rates of breast cancer worldwide have 
decreased in the last decade, with an estimated annual percentage charge of -2% year 
in Portugal.3,5 
 However, despite the decrease in mortality rates, BC incidence continues to rise, 
with a concerning increase of 20% newly diagnosed cases since 2008.6 This increase 
has been attributed to economic growth and societal changes associated with poor 
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dietary choices and lack of physical activity, both been considered major risk factors 
for the development of the disease.6 
1.1 Background 
1.1.1. What is Breast Cancer 
 A woman's breast is made up of lobules (glands that can make milk), ducts 
(small tubes that carry milk from the lobules to the nipple), fatty and connective tissue, 
blood vessels, and lymph vessels (Figure 1). Most breast cancers begin in the cells that 
line the ducts.7  
 The lymph system is one of the main ways breast cancer spreads. Normally, 
lymph nodes, which are filters connected by vessels that carry a clear fluid called 
lymph, are small, bean-shaped tissues that contain a certain kind of immune system 
cells that try to catch and trap cancer cells before they reach other part of the body.8 
 Most of the lymph vessels of the breast drain into lymph nodes under the arm 
(axillary nodes); lymph nodes around the collarbone (supraclavicular and 
infraclavicular lymph nodes); and lymph nodes inside the chest near the breastbone 








Figure 1: on the left side - lymph nodes distribution; on the right side - inside of a 
breast (http://www.cancer.gov/types/breast) 
 
When a lump or spot is discovered in the breast, a complete physical exam 
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(bimanual palpation of the breasts and locoregional lymph nodes assessment) and an 
imaging test (bilateral mammography, ultrasound of the breast and regional lymph 
nodes and MRI) are performed to look more closely to the chest and to help finding 
abnormalities.7,9 
 After the diagnosis of breast cancer, disease stage should be assessed to help 
organize the different factors and some of the personality features of the cancer into 
categories, in order to best understand prognosis, to guide treatment decisions and to 
provide a common way to describe the breast cancer so that results of the treatment can 
be compared and understood.8,10 The tumor-node-metastasis (TNM) staging system is 
the most common system used to describe the different stages and it was first 
implemented by Pierre Denoix in 1942.10 It is based on whether the cancer is invasive 
(cancer has grown into normal tissues and cancer cells have spread to other parts of the 
body through the blood or lymph system) or non-invasive  (cancer that stay within the 
milk ducts or milk lobules in the breast), the size of the tumor (T), how many lymph 
nodes (N) are involved, and whether it has spread to other parts of the body (M for 
metastasis).7  
1.1.2. Breast Cancer Staging  
 So, accordingly with TNM system BC is divided into Stage 0 used to describe 
non-invasive breast cancers. There is no evidence of cancer cells or non-cancerous 
abnormal cells breaking out of the part of the breast, in which they started, or getting 
through to or invading neighboring normal tissue.  
 Stage I the tumor has <2cm and it can be found in small groups of cancer cells 
in the lymph nodes. It is divided into subcategories known as IA and IB.  
 Stage II the tumor has <2cm and it has spread to the axillary lymph nodes or 
the tumor has between 2-5cm but it hasn’t spread to the axillary lymph nodes. It is 
divided into subcategories known as IIA and IIB. 
 Stage III the tumor can be any size and it has spread to the chest wall and/or 
skin of the breast; or it has spread to 10 or more axillary lymph nodes; or the cancer has 
spread to lymph nodes above or below the collarbone; or the cancer has spread to 
axillary lymph nodes or to lymph nodes near the breastbone. It is divided into 
subcategories known as IIIA, IIIB and IIIC. 
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 Stage IV the tumor has spread beyond the breast to other organs of the body, 
such as bones, distant lymph nodes or skin, lungs, liver and brain. The words used to 
describe stage IV breast cancer are advanced and metastatic. 
 It is not known what exactly causes BC but it is known that some risk factors 
such as diet (associated with obesity), alcohol, age, genetic predisposition and physical 
activity contribute to the rising incidence of the disease. However, the presence of a 
risk factor, or even several, does not mean that a woman will get breast cancer. 
Although many risk factors may increase the chance of having breast cancer, it is not 
yet known just how some of these risk factors cause cells to become cancer.7,9 
1.1.3. Breast Cancer treatment 
 The most common treatments for BC are surgery, radiation therapy, 
chemotherapy, hormonal therapy and biological therapy.  
 When developing a treatment plan there are factors to consider such as the type 
of BC, age, menopausal status, overall health and personal preferences or situation. 
Other factors, regarding the tumor, need to be taken into consideration such as the stage 
of cancer (size of tumor and if it has spread); grade of cancer (how cancer cells look 
and behave); hormone receptor status (if cancer cells have receptors for estrogen and 
progesterone); HER2 status (HER2 is a protein on the surface of the breast cells that 
promotes growth).11 
 After considering for this factors, the patient will then be treated with the 
following options: a) surgery, the most common treatment where the main goal is to 
remove completely the tumor from the breast. There are two different types, breast-
conserving surgery and mastectomy (remove the whole breast). This treatment may be 
combined with radiation therapy, chemotherapy and hormonal therapy; b) radiation 
therapy, where high doses of radiation are applied to destroy cancer cells. Works by 
damaging the cancer cells repeatedly leaving no time to repair themselves in between 
daily treatments; c) chemotherapy, which is the administration of drugs, usually 
through a tube into the vein, to destroy cancer cells. Drugs slow or stop cancer cells 
from growing, multiplying or spreading to other parts of the body; d) hormonal 
therapy, as mentioned before, some BC tumors have hormone receptors. When the 
estrogen or progesterone attach to the tumor they can stimulate growth. This therapy 
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reduces the levels of these hormones in the body or blocks their effect on cancer cells. 
This therapy is often given after surgery, radiation and chemotherapy to reduce the risk 
of cancer coming back; e) biological therapy works with the immune system to help 
protect the body from the disease.11 
1.1.4. Follow up care 
 The transition from active treatment to post treatment care is critical to long-
term health. When treatment ends some women feel lost, anxious and worried that 
cancer might come back. Some women may also have low self-esteem due to loss of 
breast, hair, scars and lack of mood for sex. The inclusion in support groups for women 
who survived is of extreme importance to help regain confidence, improve response to 
treatment, speed recovery, reduce risk of recurrence and improve quality of life.11,12  
  Cancer related fatigue (CFR) is a highly prevalent and multifactorial symptom 
classically defined as ‘a persistent, subjective sense of tiredness related to cancer or 
cancer treatment that interferes with usual functioning’. This symptom does not get 
better with rest and is very common in breast cancer survivors (BCS).13  
A survivor is anyone who has been diagnosed with cancer, from the time of 
diagnosis through the rest of life.12 For some survivors, this kind of fatigue lasts a long 
time after treatment and can make it hard for them to exercise. A study conducted by 
Winters-Stone et al14 reported that women with lower extremity muscle weakness, high 
body fat and lower physical activity levels had greater fatigue. The specific etiology of 
CRF is still unknown but it is frequently associated with a wide variety of psychosocial 
factors (e.g. clinical depression), and exacerbating symptoms (e.g. chronic pain, 
nausea) as well as treatment side effects.13,15 Studies have shown that patients who 
follow an exercise program tailored to their needs feel better physical and emotionally 
and it helps reduce fatigue.7,16   
 The post-surgery period is also crucial due to the possibility of developing 
complications, such as lymphedema, reduction in muscle function, decrease in upper 
limb functionality and muscular strength.17 
 Although adjuvant therapy combinations and advances in early detection have 
improved survival rates (5 year survival rates of approximately 90%)17-21, BCS often 
report side effects such as weight gain, unfavorable changes in body composition and 
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exhibit reduction in muscle strength (impaired shoulder function with decrements in 
shoulder muscular strength, shoulder mobility and functional capacity) associated with 
cancer related symptoms.17,20 Limitations in upper body strength such as pushing, 
lifting, reaching were reported as especially problematic in this population.22 Such 
limitations may be due to surgical trauma and activity avoidance.20  
 It is important to introduce BCS in exercise programs to help them recovering 
their strength and reduce their weight so they can recover their self-esteem and quality 
of life.   
1.2. Muscular Strength and Breast Cancer 
 The skeletal muscle (SM) is the largest organ in the human body, constituting 
40-50% of total body mass in healthy non-obese humans.23 It is responsible for 
performing muscular contractions, generating external mechanical force, which enables 
the realization of daily activities and exercise and plays an important role in primary 
and secondary disease prevention as an essential regulator of metabolic and 
inflammatory homeostasis.23,24 It is also an influential organ in hormonal, immune and 
metabolic function.25 
Cancer treatments have acute and chronic effects on the muscle system. The 
loss of lean muscle mass results in muscle weakness, decreased functional work 
capacity, decreased flexibility and reduced mobility. These series of events occur due 
to a decline in protein synthesis in conjunction with enhanced protein catabolism caused 
by cancer treatment and consequent deconditioning, leading to a diminished quality of 
life.17,19 The contractile and metabolic proteins that are lost are responsible for muscle 
contraction, force generation, extensibility and the production of energy (ATP).19 
The muscle has a very important role in whole body protein metabolism in the 
response to stress and therefore prevention of many pathologic conditions and chronic 
diseases.24 Maintenance of the protein content of certain tissues and organs such as the 
skin, brain, heart and liver is essential for survival. These tissues and organs, in the post 
absorptive state, rely on a steady supply of amino acids via the blood to serve as 
precursors for the synthesis of new proteins to balance the persistent rate of protein 
breakdown that occurs in all tissues. However, the stressed induced by advanced cancer 
or traumatic injury, imposes greater demands for amino acids from muscle protein 
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breakdown. Physiologic responses necessary for recovery lead to the accelerated 
synthesis of protein due to the greater demand of amino acids. Studies suggest that a 
protein intake >3g.kg.d is required to provide the necessary precursors for the synthesis 
of protein for normal healing of, for example, a burn injury in 50% of whole body. This 
means that individuals with limited reserves of muscle mass respond poorly to stress.24 
 Despite the efficacy of cancer treatments in improving survival, BCS usually 
suffer from substantial impairments that affect their level of physical activity such as 
increased body fat, reduced aerobic exercise capacity and muscle weakness.26 These 
are well known risk factors responsible for loss of muscular strength, which leads to a 
poor quality of life.14,25,27-31 Also, deconditioning during active treatment may 
contribute to declines in upper and lower extremities strength,13,18,32 regardless of 
disease stage.18,23,30   
 The role of muscular strength in the performance of activities of daily living 
and exercise, as well as in the prevention of chronic diseases, is increasingly being 
recognized. Important findings suggest that poor muscle strength is a predictor of death 
from all causes, cardiovascular disease and cancer.27,33-36 
 Reduced muscle strength is associated with loss of physical functionality and 
with negative impact on recovery after surgery or illness, which partly explains the high 
predictive power of muscle function tests.35 In addition, muscular strength has been 
recognized as an important health related component of fitness and has been shown to 
be positively related to cardiorespiratory fitness.36,37 
 The loss of muscle mass is detrimental for cancer survival. A significant portion 
of patients return for rehabilitation treatment after several months to even years after 
discharge, with several complaints of upper limb dysfunction that incapacitate 
performance of daily tasks.38 Evidence suggests that the ability to perform physical 
tasks in daily life is determined by a threshold level of muscular strength.31 Increasing 
the physical activity level during and after the treatment may improve the muscle 
strength and control the atrophy as well as improving quality of life outcomes.30,31 A 
study performed with BC patients by Vardar-Yagli et al30 found a positive association 
between physical activity levels and peripheral muscle strength. Another study31 
performed with cancer patients found that muscle strength was strongly related to 
physical functioning before treatment and changes in muscle strength were correlated 
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with changes in physical functioning. In addition to this studies, Harrington et al.26 
found that all strength measures assessed in his study were decreased in the BCS when 
compared to healthy subjects.39 
 Skeletal muscle has a greater adaptability when given appropriate training 
stimuli, even in cases of severe muscle atrophy and fatigue. Enhancing lean body mass 
size and function will improve survival after cancer treatment.25,31  
 In order to determine the severity of SM loss, muscle strength needs to be 
assessed. The exertion of muscle contraction is measured as muscle strength.23 
1.2.1. Measures of Strength 
There are several methods for the measurement of voluntary and involuntary 
muscle function. One method used to determine involuntary muscle contraction is 
electrical stimulation at various frequencies but constant isometric length. Although 
this method is considered the superior procedure in regard to objectivity, it is not 
suitable for clinical routine. Regarding measurements of voluntary strength (handgrip, 
knee extension and hip flexion strength) the handgrip is the most common measure of 
muscle function and functional capacity for clinical purposes due to its easy use, 
reliability, validity, feasibility, generalization of overall strength, since it correlates 
with elbow flexion strength, knee extension strength and trunk extension strength and 
because it is a significant predictor of health related quality of life in cancer 
patients.17,18,27,32,35,36,40 
 Grip strength has been shown to be a predictor of postoperative complications, 
functional limitations, functional decline, disability and mortality.18,27,36,41 However, as 
recently shown by Norman et al.42 mortality prediction of handgrip strength is 
dependent on which further parameters are included in the regression models. Handgrip 
strength predicted 6 months mortality in cancer patients but lost its significance when 
bioelectrical phase angle was introduced in the model.35 Also, several factors are 
negatively associated with handgrip strength in BC such as mood, fatigue, pain, 
hypersensitivity and neck shoulder mobility.17 Depressed mood is a potential 
confounder of the association between handgrip strength and mortality because it is 
associated with increased risk of mortality and risk of accelerated decline in muscle 
strength.43 Fatigue in cancer can also have a negative impact on generating a maximal 
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voluntary handgrip contraction, meaning that women with lower strength have more 
fatigue compared with women with higher strength.14,32 
 Several studies have shown that having low muscular strength is a predictor of 
all-cause mortality, as well as mortality due to cardiovascular diseases and cancer in 
healthy and diseased people23,32-34,36,44 and so it seems important to assess handgrip 
strength and to determine whether and to what extent the measured values are 
abnormally low.37 Handgrip strength is strongly correlated with post-operative 
complications and has been reported to be predictive of length of hospital stay, loss of 
functional status, body cell mass depletion, post-surgery complication, short-term 
survival in hospitalized patients as well as associated with probability of premature 
mortality and earlier onset of disability.32,35,45,46  
In conclusion, higher levels of strength will have a protective effect from 
disability and mortality.18,36,47 
1.2.2. Handgrip Test 
The gold standard for assessment of muscle strength is the force exerted in a 
maximum voluntary contraction with force output measured by a dynamometer.23,36,40  
The strongest evidence in relation to mortality has been reported for the handgrip 
strength test.36,37 This test reflects the maximum strength derived from combined 
contraction of extrinsic and intrinsic hand muscles, which leads to the flexion of hand 
joints. It was originally developed for hand surgery but quickly become the focus of 
interest in numerous studies due to its feasibility and prognostic relevance.35 
Therefore, handgrip strength test has been recommended as an assessment of 
muscle function for oncology rehabilitation and it is an important indicator of health-
related quality of life in BCS.18,32,36,48 Grip strength test is commonly used to evaluate 
the integrated performances of muscles by determining maximal grip force produced 
in one muscular contraction.40 It likely reflects the combined influences of genetic 
predisposition, acquired modifications of physical constitution, aging processes and 
chronic diseases.47 It has been used in a variety of clinical areas and for multiple 
purposes such as the assessment of upper limp impairment, evaluation of work capacity 
for those with hand injury and other work-related injuries, the evaluation of people with 
other impairments and disabilities such as chronic fatigue syndrome and muscular 
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dystrophy, determining the efficacy of different treatments for people with a range of 
disabilities, part of an overall fitness assessment and determining the level of effort 
exerted.49 
 A wide range of instruments is available to measure grip strength. There are 
four basic categories for the measurement of handgrip strength: a) hydraulic which is 
a sealed system that records grip strength in kg or pounds of force. This includes the 
Jamar dynamometer, a measure with static grip with handles that can be adjusted to 5 
different positions (2.5, 3.8, 5.1, 6.4 and 7.6 cm apart). This is the most widely used 
instrument; b) pneumatic instruments which uses the compression of an air-filled bulb 
or bag to determined grip pressure. Commonly used by individuals who have painful 
hands or fragile skin, as they are viewed as being more comfortable to grasp and softer. 
A criticism is that this method can only measure the pressure of grip and not its force;50 
c) mechanical instruments that record grip strength based on the amount of tension 
produced in a steel spring; d) strain gauges: commonly measure grip strength in 
Newtons of force.49 
The California Medical Association Committee studied some dynamometers 
and found that the Jamar dynamometer was “perfect to the extent that its sealed 
hydraulic system is a nearly leak proof as any mechanical appliance can be made”, 
recommending it as the best measure of grip strength.50 This Committee summarized 
three basic factors of grip measurements: grip is a force, grip is not a pressure and the 
measurement of grip must be in force units such as pounds or grams.50 
 Therefore, the Jamar dynamometer has been reported to be the most reliable, 
valid, fast and easy to perform instrument with the highest calibration accuracy for the 
measurement of grip strength, as well as better repeatability than other equipment and 
has been recently validated in advanced cancer patients.32,37,48-51 
Although there is not any consensus in measurement protocols, consistency is 
crucial since posture, arm side and handle position of the dynamometer easily alter 
maximum grip strength.35,50 The American Society of Hand Therapists (ASHT) 
purposes a methodology associated to high intra- and inter-test reliability. According 
to them, the assessment of grip strength should be made sitting in a straight-backed 
chair with the feet flat on the floor, shoulder adducted and neutrally rotated, elbow 
flexed at 90º with forearm in a neutral position.17,35,49,51 This protocol was developed to 
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be used with the Jamar dynamometer.49 Most of the studies follow the ASHT protocol 
in an attempt to control known risk of errors48 however, the handgrip strength values 
depend on many other factors such as the model of the dynamometer in use, inadequate 
calibration, sample characteristics (physical activity level, etc.) and probably ethnical 
differences.46 
 Regarding the handle position, every individual should use the most 
comfortable, however, it seems advantageous to standardize the method as much as 
possible and reports suggest that the second position is the most comfortable and has 
the higher grip strengths.48-50,52 It was also reported that a 3 second time of contraction 
should be used as it is sufficient to obtain a maximum reading without exposing the 
patient to adverse effects such as increased blood pressure or heart rate, which 
accompanies prolonged isometric contraction.32,49,51 
 This technique has allowed for large cohorts of handgrip strength data to be 
obtained and to make predictions concerning key health indicators, especially in aging 
and clinical populations where malnutrition and cachexia are prevalent.32 
  A study held by Kilgour et al.32 was the first to link handgrip strength with 
survival in advanced cancer. They also found that an overall reduction in handgrip 
strength was related with the appearance of sarcopenia.32  
  A systematic review conducted by Neil-Sztramko et al18 pooled grip strength 
data from 26 studies in BC population and reported that in women off treatment the 
mean value was 22.8 kg (95% CI 20.6 to 25.1).18 
 Normative values are essential if informed decisions are to be made about the 
individual’s status relative to the general population. 
 Even though the distribution of a given measure for a specific population does 
not necessarily mean the health state of the population, it is reasonable to assume that 
handgrip strength values in the lower end of the distribution may be indicative of 
several outcomes.45,46 
1.2.3. Muscle Dysfunction and Obesity 
 Cachexia is a complex metabolic syndrome associated with underlying illness 
and characterized by loss of muscle with or without loss of fat mass.53,54 The loss of 
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skeletal muscle arises from a fall in protein synthesis and an increase in protein 
degradation, which is a side effect of cancer treatment.17,23,53,55-57 It is often 
misdiagnosed as a condition of weight loss but it is actually a highly complex metabolic 
disorder and one of the most frequent effects of malignancy, which is why within 
oncology, interest in muscle function has traditionally been confined to the clinical 
entity of cancer cachexia.23,58  
 Cancer cachexia is characterized by severe muscle wasting, systemic 
inflammation and malnutrition leading to both acute and chronic impairments in 
various aspects of physical function18,23,58 such as extensive loss of muscle mass, 
strength and metabolic function24 and reduced fitness levels17, and contributes to nearly 
one third of all cancer deaths.58  
 The cachectic state is particularly problematic in cancer, typifying poor 
prognosis and often lowering the responses to chemotherapy or radiation treatment.58 
In a study conducted by Wolfe et al24 it was found that the amount of body protein, 
which is related to the amount of muscle mass, predicted recurrence in lung cancer 
patients that were receiving radiation therapy.   
 Although cancer cachexia is associated with loss of SM, gain of adipose tissue 
can occur, culminating in the condition of sarcopenic obesity.17,54 Martin et al54 found 
that most of the cancer patients of his study were more commonly overweight or obese 
and often had occult severe pre-existing muscle depletion. Sarcopenia (progressive loss 
of muscle mass and function)24 itself is an independently prognostic of lower survival 
in obese patients with cancer.54 According to Cantarero-Villanueva et al15 the lack of 
strength associated with an increased body mass index (BMI) may be related to 
sarcopenia and a decreased grip strength.  
One common side effect that occurs in over 50% of BCS is the gain of weight, 
which can be related to the development of comorbid conditions that affect survival15,59-
62 as well as risk of cancer recurrence due to increasing endogenous estrogen 
production,63 with most explanations focusing on adiposity rather than body weight per 
se.61,64,65 Evidence62 suggests that reported weight gain happens during the first two 
years after diagnosis, with the weight gained ranging from few grams to several 
kilograms. In a study conducted by Arpino et al62 it was shown that weight gain is also 
associated with changes of body fat composition, namely an increase of waist 
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circumference and hip circumference. Although weight is the simplest anthropometric 
index of excess adiposity, it does not distinguish between fat free tissues (comprised 
primarily of muscle, bone and extracellular water) and adipose tissue.63 Waist and hip 
circumference and waist-to-hip ratio (WHR) are additional measures of body fat 
distribution that provide an index of both subcutaneous and intra-abdominal adipose 
tissue.62,66-68 The evidence on abdominal obesity on BC survival highlights the need of 
using general obesity (body mass index) as well as fat distribution (waist circumference 
and WHR) to evaluate prognosis.69  
It is well established that obesity has an impact on BC occurrence and it is 
important to distinguish 2 types of obesity: android (WHR>0.8) in which fat is mainly 
distributed in the upper body (shoulders and abdomen) and gynoid (WHR<0.8) where 
fat accumulates in the lower part of the body (buttocks, thighs).66 According to 
Pacholczak et al66 women with BC present an android type of silhouette with the 
distribution of fat tissue present in the central and upper parts of the body. They also 
mention that this type of obesity cause more pronounced abnormalities in metabolic 
and hormonal systems66 perhaps because of its relation with visceral adiposity.70 
Women with increased WHR have a twofold higher risk of all-cause mortality 
compared with women with a lower WHR, in models adjusted for physical activity and 
BMI.69 Therefore, women with central adiposity may be at higher risk of BC than 
women whose fat is primarily distributed subcutaneously over hips and buttocks70 
because abdominal obesity, is associated with an elevated level of circulating insulin 
that is mitogenic, anti-apoptotic, and pro-angiogenic, and has been found to be 
associated with worse BC prognosis.68 Several adipokines produced by adipose tissue 
are related to hyperinsulinemia and angiogenesis promotion, which is a major 
contributor to the aggressive behavior of BC.69  
Cancer patients with a body mass index (BMI) > 35kg/m2 have worse disease 
free survival than those of normal weight, independent of age, race, treatment and sex.15 
BMI is a measure of weight adjusted for height that provides a better approximation of 
the proportion or total amount of adipose tissue in the body than does weight alone.63 
The validity of BMI as a measure of adiposity is further supported by its association 
with obesity-related risk factors such as total cholesterol and blood glucose.63 It’s 
calculated as weight in kilograms (kg) divided by height in meters squared (m2).62 The 
classification goes as follows: underweight (BMI < 18.5), normal weight (BMI 18.5 to 
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24.9), overweight (BMI 25-29.9) and obese (BMI > 30) and is used in adults > 20 years 
old.71 When the BMI is over 25 kg/m2 that person is at increased risk of developing 
health problems due to abnormal or excessive fat accumulation.68,71 Central obesity 
promotes a concomitant increase in WHR at the same level of BMI therefore, and with 
increasing evidence of health risks associated with abdominal fat, WHR and waist 
circumference have been commonly used in epidemiologic studies as measures of 
central adiposity.63,68 World Health Organization cutoff points of waist circumference 
and WHR for substantial increased risk of metabolic complications in women are >88 
cm and  0.85, respectively.69 
 A sedentary lifestyle combined with an unhealthy BMI increases the risk of 
cardiorespiratory diseases in BCS, which is among the most frequent concomitant 
comorbidity in women with BC.15 In addition to this, abdominal obesity is a 
predisposing factor67 which means that having a waist circumference superior than 88 
cm is associated with and increased risk of this comorbidity. This value of waist 
circumference is exceeded by almost 100% of the obese BC patients and is linked with 
increased mortality.15 
 Due to all these factors it is expected that muscular strength is reduced in obese 
patients due to a decreased level of fitness.15  
 All cancer patients are subjected to a wide range of degenerative factors, which 
are all potent causes of muscle dysfunction including aging, malnutrition, physical 
inactivity and factors directly related to disease pathophysiology and therapy toxicity.23 
Lintermans et al72 reported a negative impact of taking aromatase inhibitors – 
medication that suppresses the plasmatic concentration of estrogen, such as Anastrazol 
- on the SM system with more than half of patients complaining of this with loss of grip 
strength. The loss of SM explains why patients with cachexia have a reduced mobility 
and quality of life, together with a shorter life span.57  
1.3. Physical Activity 
 In long-term cancer survivors, physical activity (PA) has gained interest as a 
modifiable lifestyle factor that may improve mortality.73  
According to some authors30,31,64,74-77 exercise interventions in cancer patients 
and survivors are associated with favorable outcomes such as achievement of a healthy 
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body weight, reduced recurrence risk, mitigating cancer treatment side effects (i.e. 
fatigue), improvements in quality of life (QOL), psychological well-being, body image 
as well as improvements in physical functioning (i.e. oxygen capacity, flexibility, 
strength measures), anthropometric measures (i.e. body weight) and health related 
biomarkers (i.e. blood pressure, heart rate). Therefore, it should be a priority to have an 
appropriate weight, a healthful diet and a physically active lifestyle aimed at preventing 
recurrence, second primary cancers and other chronic conditions.12 
A report from Europe’s largest survey assessing outcomes in people living with 
and beyond cancer show that <25% met the current physical activity guidelines, 43% 
had trouble with fatigue and 45% experience fear of disease recurrence.77 Another 
study78 mention that up to 70% of BCS do not meet recommendations of 150 minutes 
per week of moderate to vigorous intensity PA (e.g. brisk walking, jogging, swimming). 
 The combined high prevalence of inactivity and sedentary time may be 
particularly concerning for BCS given their already heightened risk for poor health and 
disabilities.78 Several studies79-82 show that women who engaged in PA after a diagnosis 
of BC had a statistically significant 20-50% lower risk of death from BC, especially if 
this PA was within the guidelines. Hormonal changes induced by exercise, such as a 
reduction of circulating estrogen concentrations mediated by a reduction in adipose 
tissue or PA independent increase in the amount of sex hormone-binding globulin and 
improvement in insulin sensitivity may explain the relationship between PA and 
survival among BCS.73,80,81 Additionally, PA may also improve the immune response, 
possibly by promoting killer cell, macrophage and cytokine activity, as well as up 
regulating antioxidant enzyme activity, which may protect against DNA damage.73 
 Studies show that regular exercise after BC diagnosis is significantly associated 
with improved overall and disease free survival following a dose response pattern81 and 
that PA influence extends to women regardless of age at diagnosis, stage of disease at 
diagnosis and post-diagnosis BMI.80 
 In a study conducted by Bradshaw et al73 the beneficial effect of PA appear 
slightly stronger in the time period following diagnosis and also among women who 
were not overweight in the year before diagnosis for both all cause and BC specific 
mortality. This study was able to follow PA over several years allowing to evaluate the 
associations of activity near or after diagnosis.80,81,83 
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 Monitoring physical function during and after treatment may help health 
professionals to identify declines in order to increase muscle strength and control the 
atrophy, which will improve morbidity, mortality and quality of life.17,18,25,30,53  
 To monitor trends and evaluate public health or individual interventions aiming 
at increasing levels of PA, reliable and valid measures of habitual PA are essential.  
 Several routine instruments are available to measure PA, including self-report 
questionnaires, indirect calorimetry, direct observation, heart rate telemetry and 
movement sensors.84,85 All these methods have well known limitations and for PA there 
is currently no perfect gold standard criterion.86  
 In large-scale cohort studies questionnaires are more frequently used due to 
their low cost and easy administration.84 There are at least 85 self-administered PA 
questionnaires for adults but the International Physical Activity Questionnaire (IPAQ) 
is the most widely used.85 The IPAQ was developed in an attempt to standardize 
assessment of the prevalence of PA in different countries and cultures around the 
world.87 Its reliability and validity was tested in 14 centers in 12 countries during the 
year 2000 with the support of World Health Organization and centers for Disease 
Control.84,88 From this study it was suggested that the last 7-day short form of IPAQ 
could be used for national and regional prevalence studies.88 IPAQ has two versions 
available: 31-item long form (IPAQ-LF) and the 9-item short form (IPAQ-SF). The 
short form records the activity of 4 intensity levels: 1) vigorous-intensity such as 
aerobics, 2) moderate-intensity such as leisure cycling, 3) walking and 4) sitting.85 The 
short version is specific to the ‘last 7 day recall’ because the burden on participants to 
report their activity is smaller85 and there is no difference between the reliability and 
validity of the short and long form.88 
 Although IPAQ-SF is recommended and widely used, some studies85,87 found 
that this method tends to overestimate the amount of PA reported compared to an 
objective device. Hence, the evidence to support the use of IPAQ-SF as an indicator of 
relative or absolute PA is weak. However, a study conducted in BCS assessed PA with 
the IPAQ-SF and found a positive association between PA levels and peripheral muscle 
strength, showing the significant protective effect of PA on BC risk.30 
 As mentioned before, BCS and cancer patients have less muscle strength 
compared with healthy people.15 Growing evidence suggests that exercise has the 
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capacity to mitigate and/or reverse muscle dysfunction in patients with cancer23,30 as 
shown by Christensen et al23 BC patients who performed resistance training during 
chemotherapy had an increase of 0.8kg of muscle mass. Another study19 suggested that 
moderate-intensity exercise can provide a sufficient physiological stimulus to improve 
muscular performance in cancer survivors, whether exercise is performed during or 
after cancer treatment. But it is important to note that, according to Doyle et al12 low to 
moderate intensity for healthy population may be of high intensity for cancer survivors. 
The ability to perform physical tasks in daily life is determined by a threshold 
level of muscular strength and that’s why strength training in cancer patients would 
seem to be a potent physiological intervention for regaining lost muscles and improving 
QOL.31 
1.4. Water Compartments and Breast Cancer 
 Being the major constituent in the human body, water comprises about 40-70% 
of the entire body mass and constitutes approximately 72-74% of free fat mass (lean 
tissues) and approximately 10% of fat mass (relatively nonaqueous).89-91 The total 
amount of water in the body referred as total body water (TBW) is divided in two main 
compartments: intracellular water (ICW) corresponding to the fluid within the cells and 
it is 66% (2/3), and extracellular water (ECW) which includes all fluid outside the 
cells 33% (1/3). These fluid compartments are separated by plasma membranes that 
surround the cell.92 
 When conditions outside the body change, these changes are reflected in the 
composition of ECW, which surrounds the individual cells of the body. Uncorrected 
deviations in factors such as oxygen and carbon dioxide exchange, can lead to disease 
and/or death. Therefore it is crucial to maintain concentration gradients and the 
movement of solutes and water across barriers to preserve normal body function.92 In 
some clinical conditions, alterations in body hydration and fluid distribution cause 
differences in the ratio ECW to ICW, and with certain drugs, the body can retain or lose 
significant amounts of water and therefore present different proportions of TBW.92,93 
Adequate water volume is essential for optimal thermoregulation, 
cardiovascular and metabolic function. A 3-4% reduction in hydration is likely to cause 
a reduction of 2% in muscular strength.94 In a recent study conducted in judo 
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athletes by Silva et al.94, it was found that independently of changes in body weight and 
arm lean soft tissue, athletes that decreased the intracellular water (ICW) compartment 
were more likely to reduce grip strength.94   
 Additionally, TBW estimations have been used to monitor nutritional status and 
identify disease states, such as dehydration and chronic kidney disease.95 
 In healthy individuals the hydration of fat-free mass (FFM) and the ratio 
between ECW and TBW are tightly regulated. In malnourished patients and under a 
variety of other diseases there is usually a relative increase in ECW, which often results 
in an increase of TBW.96 
 The most significant confounding variable in BCS is edema of the distal 
extremities, which may result from lymphedema, and will affect impedance 
measurements.93 
 Lymphedema is the most problematic and dreaded complication of BC 
treatment, particularly after surgery or lymph node removal,17,97,98 characterized by the 
accumulation of protein-rich extracellular fluid, resulting from damaged or blocked 
vessels99 leading to a significant increase in the volume of the affected limb, resulting 
of an impairment in the ability of the lymphatic system to drain the proteins and 
macromolecules of the interstitium.17 It is an incurable, progressive, disfiguring and 
disabling disorder that is often misdiagnosed and treated too late or not treated at all.100 
It may present immediately or years after treatment.97 Incidence may vary from 6-
30%.21 Early treatment due to early diagnosis may prevent progression to the chronic 
phase.100 Despite the causes of lymphedema, such as stiffness and decreased range of 
motion of the affected limb joints, handgrip strength test, mentioned in the previous 
chapter was unchanged regardless the presence or absence of lymphedema.17 
 Measurements of TBW and ECW involve the use of invasive tracer-dilution 
techniques. These techniques are expensive and time consuming for routine procedures. 
Until recently it has not been feasible to use field body composition methods, such as 
bioelectrical impedance analysis (BIA), to assess routinely the nutritional status of 
hospitalized patients.96 
 Data from the last decade indicate that BIA was able to predict the onset of 
lymphedema 10 months before clinical diagnosis.99,100 At low frequencies, 
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lymphedema assessment through BIA detects ECW changes. Increases in the volume 
of this fluid reflects the contribution of lymph accumulation when the subject being at 
study is at risk of developing lymphedema.100 
 Intracellular fluid is unaffected by the advert or progression of the disease. 
Hence, an ECW/ICW ratio is constructed to help detecting the early onset of 
lymphedema. This ratio is a validated method and appears to have equal or better 
sensitivity than other techniques in detecting lymphedema.100,101 However, if assessed 
too early, as within 3 months of surgery, normal postoperative swelling could be 
misconstrued as evidence of lymphedema.97 A participant was classified as having 
lymphedema when impedance ratio was more than 3 standard deviations above 
population mean.97  
1.4.1. Bioelectrical impedance 
The principles of bioelectric impedance (BI) have been established for more 
than 40 years but methods for estimating components of body composition, specifically 
total body water, intra and extracellular water, and fat-free mass, are comparatively 
recent.102  
 The use of BI to estimate body composition is based on the principle that an 
electrical current flows at different rates through the human body and is resisted by 
body tissues and water.93 It is also based on the greater electrolyte content and 
conductivity of free fat mass (FFM) compared to that of adipose tissue or bone and 
upon the geometrical relationship between impedance and volume of the 
conductor.102,103  
 Therefore, impedance (Z) is the frequency dependent opposition of a conductor 
to the flow of an alternating current and is composed by two vectors: resistance (R) and 
reactance (Xc).93,102 
The R is described as pure opposition of the conductor (intracellular fluids, body 
fluids and electrolytes) to the flow of an electric current and is related to the amount of 
water present in the tissues.104 The Xc is the resistive effect produced by tissues 
interface and cell membranes, is the inverse of capacitance, where capacitance is the 
storage of energy in a circuit by a capacitor.61,105 In human body, capacitance occurs 
when regions of high conductivity (i.e. ECW and ICW) are separated by regions of low 
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conductivity (i.e. cell membranes).105 Therefore, ECW and ICW act as resistors in 
parallel while the cell membrane behaves as an imperfect capacitor and introduces a 
reactive and hence frequency dependent component to the total impedance.106 
 At 5kHz signal pathway is only conducted through ECW because there is very 
little capacitive penetration of the signal into the intracellular volume and it’s assumed 
that measured impedance is totally resistance.106,107 At midrange frequencies (e.g. 
50kHz) a small amount of intracellular penetration occur due to some capacitors being 
electrically charged. Therefore, at 50 kHz the resistance is lower than at 0 kHz because 
there is a greater cross sectional area and a shorter path to destination electrode.105 At 
high frequencies (>500kHz), the current is able to penetrate the cell membrane of the 
intracellular compartment107, taking a more direct pathway through the body, therefore 
including both water compartments105,106 assuming resistance index is linearly 
correlated with TBW.107 
 Therefore, the 0/ kHz parallel model (Cole-Cole) is the most accurate model 
for the analysis of water compartmentalization. The success of this method can be 
attributed to the fact that ECW and ICW are the major electrical conductors in the body 
and they reside adjacent to each other, with ICW being isolated from ECW by low 
conductivity membranes.108 This model is very useful for the assessment of body water 
in diseased populations in which the ratio ECW to TBW is altered.107 
 BI depends on static assumptions and dynamic relationships regarding electrical 
properties of the body. Anthropometric measurements (e.g. height, weight, age, sex, 
race, etc.) are often used in many of the BI prediction equations.106,109 These parameters 
are included to reduce the effects of interindividual variance in R and Z values, related 
to differences in body size and in shape and to increase the prediction accuracy of body 
composition estimates.109 It is also important to control some aspects to guarantee the 
validity, reproducibility, and precision of the measurement in similar populations. 
Therefore, some standardizations have been suggested in order to replicate results, such 
as the subject body position, length of time in supine position before measurement, 
correct stature measurement, skin preparation with alcohol before electrode placement, 
electrode position, hydration and menstrual cycle, consumption of food and beverages 
before test, ambient air and skin temperature, recent physical activity and conductance 
of the examination table.106,109-111  
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 BI is considered to be a feasible filed method as it is an easy, portable, 
inexpensive, noninvasive, and less time consuming method,61,93,105,112-114 especially if 
compared with laboratorial methods such as deuterium dilution, tritiated water dilution, 
bromide dilution, and even dual energy x-ray absorptiometry.104 BI results are available 
immediately and measurements can be repeated as often as desired without side effects 
for the participant.  
 Malnutrition is a frequent manifestation in patients with advanced cancer and is 
a major contributor to morbidity and mortality. Malnutrition is characterized by 
changes in cellular membrane integrity and alterations in fluid balance with an increase 
in ECW, which often results in an increase in TBW.96 As a result, measurement of body 
composition is an important component of overall nutritional evaluation in cancer 
patients.61 
 At 50 kHz the current does not completely penetrate the cell membranes but in 
normal subjects this is not particularly important because the intracellular volume 
represents a relatively constant proportion of the TBW. In patients, there may be 
significant variations in the proportions of ICW and ECW and it is more important that 
the frequency is high enough to allow the current to completely penetrate the 
intracellular space.115 Clinical advantage to monitor both ECW and ICW makes BI the 
preferred technique for future clinical research.109  
 A decrease in ECW/ICW ratio would result in a relatively lower resistance per 
unit of body water and higher TBW.114,116  
  To estimate a certain body compartment based on bioelectrical impedance 
methods it is important to choose the type of device that will be used. The single 
frequency bioelectrical impedance analysis (SF-BIA) device and multiple-frequency 
bioelectrical impedance analysis (MF-BIA) have the measured resistance and/or 
reactance incorporated into empirical prediction equations, developed by regression 
analysis.104 The bioelectrical impedance spectroscopy approach (BIS), estimates body 
composition through a mathematical modeling technique108,117 on a range of resistance 
values measured at different frequencies to extrapolate the resistance of the ECW and 
ICW.104  
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1.4.1.1. Single Frequency Bioelectrical Impedance Analysis 
 Single-frequency bioelectrical impedance analysis is by far the most widely 
available impedance methodology, which involves the application of an electrical 
current for the measurement of impedance at a single frequency, typically 50 kHz.118 
The current passes between surface electrodes placed on hand and/or foot. Some 
instruments use foot-to-foot or hand-to-hand electrodes.110  
SF-BIA strictly measures a weighted sum of ECW and ICW resistivity. 
Impedance data is entered into predictive equations derived through statistical 
regression in order to determine TBW, from which FFM is calculated according to the 
assumption that FFM is constantly hydrated at 0.73.118 However, SF-BIA cannot 
determine differences in ICW. Therefore, a problem of using a single-frequency 
measurement to predict TBW is that the sensitivity of a single high-frequency 
measurement to changes in ECW and ICW is different due to their different resistivities, 
a simple change in the ratio ECW/ICW will alter TBW resistivity and cause error.119 
As so, the SF-BIA is not valid under conditions of significantly altered hydration, but 
this does not negate its use to predict absolute FFM or TBW in normally hydrated 
subjects.110,120 In malnourished patients or under a variety of other diseases such as 
edema, there is usually an increase in ECW, which often results in and increase of 
TBW,96,110,118 when this occurs, Cole-Cole model should be used.107 
 In SF-BIA the assumption that FFM is constantly hydrated is a major limitation 
of this technique in the assessment of body composition, as FFM hydration may not be 
constant for all populations.105 
1.4.1.2. Multiple Frequency Bioelectrical Impedance Analysis 
 At 50kHz, the electrical pathway is primarily extracellular because there is very 
little capacitive penetration of the signal into the intracellular volume, which means, 
the cell membrane acts as an insulator, and it is assumed that the impedance is 
principally a function of ECW, responsible for the measured R at R0.
105,107,110,119 Thus, 
one can conclude that SF-BIA is limited in the ability to distinguish the distribution of 
body water into its intra- and extracellular compartments.121 
At infinite or very high frequencies, as it occurs in MF-BIA and BIS, the 
conduction through the ICW increases and becomes fully conductive. Impedance, or 
 35 
the total body R (R) is a function of both ICW and ECW (TBW), which is caused by 
cell membrane capacitance.106,110,119 
 Therefore, TBW assessment by SF-BIA was replaced by MF-BIA devices that 
apply the current at limited and defined frequencies (e.g. 5, 50, 100, 200 or 500kHz) 
and offer the potential of measuring TBW, ECW and ICW separately.103,118 
Due to its efficacy in accurately predict TBW, MF-BIA was used to monitor the 
efficacy of treatment for lymphedema in patients following surgery for BC. This 
method was shown to be significantly more sensitive than others to detect small 
differences in the extracellular volumes between the arms of any individual. ECW was 
elevated after clinical diagnosis of lymphedema. This index does not require 
normalization to another body segment and can be used to detect all types of peripheral 
edema including both uni- and bilateral lymphedema.101 
 There are two approaches to the use of MF-BIA data: 
1. Multiple Frequency Bioelectrical Impedance Analysis 
MF-BIA first introduced by Thomasset el al.103 used impedance data at two 
frequencies: one at very low frequencies (usually 5kHz) and the other at very high 
frequencies (typically 50, 100, 200 to 500kHz). The impedance data are applied to 
regression-derived equations in order to predict TBW, ECW, and ICW.118 
Unlike the SF-BIA, this model correctly assumes that the specific resistivities 
of intra- and extracellular fluid are different. It assumes that R at low frequencies is the 
resistance of the extracellular fluid (Re) because virtually no conduction occurs due to 
high cell membrane capacitance. On the other hand, R at high frequencies is the 
resistance of whole fluid (Rt) because there is total conduction through the cell 
membrane.118 The resistance of the intracellular fluid (Ri), is a function of both low and 
high frequency.105  
However, the use of more than one frequency gives a variability of results and 
no conclusions can be made regarding the validity of one frequency over another, in 
the prediction of body fluid compartments.105 
2. Bioelectrical Impedance Spectroscopy 
In contrast to SF-BIA and MF-BIA, BIS uses physical and mathematical 
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modeling and mixture equations (e.g. Cole-Cole and Hanai formula)108,117 to generate 
relationships between R and body fluid compartments, instead of regression 
equations.110 BIS measures the impedance across a spectrum of frequencies and can 
accommodate interindividual variation due to the mathematical modeling generated 
factors. As so, BIS provides a more direct, individualized measurement of ECW and 
ICW than other impedance approaches.118  
In commercial BIS instruments using the Cole-Cole model108, multifrequency 
impedance data are mathematically modeled to reduce the influence of artifacts at low 
and high frequencies. In this model, the body is viewed as an electrical circuit with 
intracellular and extracellular pathways in parallel and having cell membranes serve as 
capacitors for the intracellular pathway.105 
Cole model is computed by using nonlinear curve fitting to extrapolate data to 
the low and high frequency limits. This procedure generates Cole model terms, 
including Re (resistance associated with the ECW); Ri (resistance associated with the 
ICW); Cm (cell membrane capacitance); and exponent . Cole model terms are then 
applied to equations derived from the Hanai mixture theory, which is essentially based 
on the notion that the body is a conducting medium of water, electrolyte-rich tissues 
(e.g. blood and muscle) in addition to nonconducting material within it (eg, bone, fat 
and air filled spaces).120 This theory was applied to improve the Cole-Cole linear model 
as (1) it accounts for the effects of non-conducting substances in the body water, (2) 
removes the apparent population-specificity found with Cole-Cole linear equations, and 
(3) improves sensitivity to body water changes 122.  
The TBW is assumed to be the sum of ECW and ICW 118,123,124, and the FFM is 
calculated based on the mean density of the intra- and extracellular water and its 
associated material. 
 Therefore, Cole-Cole model and Hanai theory108 will be useful for the 
assessment of body water compartmentalization in diseased populations in which ratio 
ECW to TBW is altered.107,119  
1.4.2. Validation in Clinical Populations 
BI has been validated to assess body composition and nutritional status in a 
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variety of patients, including cancer.61,96,105,112,125-127 The existent data is, so far, 
inconclusive, nevertheless, BIS seem to present itself as a valid alternative to assess 
body composition and body water compartments, in clinical populations. 
In Netherlands, BIA is routinely used in surgical and oncological patients, 
where quick measurements of body compartments are needed.104 According with 
Earthman et al.,118 BIS is the only field technology available that has the potential to 
measure body water volumes and body cell mass (BCM) in the clinical setting. The 
BCM has clinical relevance because it has been defined as the total mass of 
metabolically active, living, functioning cells. A loss of BCM can cause a decrease in 
physical strength and immune function, with an increase in susceptibility to infections, 
as observed in human immunodeficiency virus (HIV) patients.118 BIA also predicts 
short-term survival in HIV patients.109 
Therefore, from a clinical perspective, the ability of BIS to accurately estimate 
BCM by quantifying ICW, as well as the ability to monitor fluid distribution between 
the ICW and ECW compartments, would greatly enhance nutrition assessment, as well 
as the overall clinical care of the patient.118 
However, according with the review of 11 studies in oncological and surgical 
patients made by Haverkort et al.,104 BIA measurements underestimated TBW and FFM 
irrespective of the equation or device used. The results of these studies indicate that the 
application of the Heitmann equation contributes, to some extent, to a valid estimation 
of TBW in patients with incurable cancer. They concluded that BIA estimations in the 
individual patient care with regard to oncological and surgical patients can be useful 
when performed longitudinally and under strict conditions.104  
Fredix et al.,128 also concluded that BI is a promising method for the assessment 
of body composition in clinical practice provided that population specific prediction 
formula are used.128  
According to Moon et al.,120 an increase in ECW, which can be due to a high 
BMI, very common in BCS, have been shown to influence BIS estimations, causing an 
overestimate in TBW. These authors suggest the application of TBW equations instead 
of predefined values automatically calculated by equipment’s, and apply those in an 
appropriate equation to predict hydration. 
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1.4.3. Phase Angle 
In healthy subjects, age, sex and BMI are the major determinants of phase angle 
(PhA). Aging is associated with a decrease in tissue mass (reduced Xc) and in TBW 
(increased R) resulting in decreased PhA. A higher PhA is observed in persons with an 
increased BMI because PhA is directly related to cell membranes (amount and 
functional status) and persons with increased BMI have more fat cells resulting in 
higher PhA values. For BMI > 40 kg/m2 an inverse relationship is observed, this has 
been attributed to a higher tissue hydration or a pathological fluid overload.129-131 
Patients often exceed normal BMI range and a differentiation between PhA as 
an indicator of body composition and cellular function altered by disease may require 
BMI-specific reference values to exclude an influence of body composition,132 since 
increased BMI is a common feature of BC patients.17,30,57 
 As mentioned before, measurement of body composition is an important 
component of overall nutritional evaluation in cancer patients and in association with 
cell membrane functional analysis it is able to reflect cell function and integrity.133 
Changes in cell integrity are characterized by malnutrition, which is a major contributor 
to morbidity and mortality and so, a predictor of shortened survival.42,134 
 Nutritional status has been evaluated through objective measures such as 
anthropometric and laboratory methods. This methods are not ideal in the clinical 
setting because they are time consuming and require well-trained staff.61 The use of 
impedance methods as a measurement of assessment of body composition and 
nutritional status overcomes the aforementioned issue and other challenges that might 
appear with the assessment in the clinical setting.131 
 We now know that cell membranes produce capacitance (Xc) by storing parts 
of the charge as a capacitor. The storage of the current creates a phase shift that can be 
regarded as the ratio of R and Xc and is expressed as phase angle .135 Bioelectrical PhA 
has consistently been shown to have great prognostic relevance with regard to 
morbidity and mortality in several conditions such as HIV/AIDS, liver cirrhosis, sepsis, 
hemodialysis, lung, colorectal and pancreatic cancer.42,131-134 PhA is the angle the 
impedance vector forms relative to the R vector, as shown in Figure 2, and is calculated 
through the following equation:  
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Phase Angle = (Resistance/Reactance)*(180/π).102 
Although the biological meaning of PhA is not well understood, it is considered 
a novel marker of cellular function,44 as reflects in one hand, the capacitance behavior 
of tissues (reactance) and is associated with cellularity, cell size and integrity of the cell 
membrane and, on the other hand, on its pure resistive behavior (resistance), which is 
dependent on lean tissue mass and tissue hydration between intra- and extracellular 
spaces.42,61,113,129,131,132,134-136 PhA is positively associated with Xc and negatively 
associated with R.61  
 
Figure 2: Diagram of the graphical derivation of the phase angle and its relationship with R, 
Xc and Z.136 
Changes in the extracellular to body cell mass ratio are probably associated with 
changes of the PhA. This ratio is a known sensitive marker of malnutrition, 
characterized by both increased ECW and decreased BCM (mainly muscle mass), 
typical features of systemic illness, and PhA appears to reflect its prognostic 
significance.42,129,136,137 Castanho et al.133 discovered a direct association between 
ECW/BCM ratio and tumor volume in lung cancer patients. 
A low PhA is associated with cell death or decreased cell integrity (reduced 
Xc)135, a loss of ICW reflects BCM loss, which is frequently accompanied by an 
increase in ECW in mainly clinical populations characterizing edema/extracellular 
accumulation and poor health42,118,138 while a higher PhA is an indicator of wellness, 
low ECW:ICW ratio,137 associated with large quantities of intact cell membranes of 
skeletal mass and BCM reflecting stronger cell function.42,61,113,130,136,139,140 Due to this 
feature, PhA is positively correlated with muscle mass as well as with muscle strength 
(assessed by handgrip strength test) in many diseases such as cancer,42,112,113,135,136,139 
representing objective functional measures with prognostic potential in these patients.44 
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Disease, inflammation, malnutrition or prolonged inactivity can result in 
disturbed electric tissue properties (cellular membrane integrity and alterations in fluid 
balance)132 that directly affect PhA. A low PhA has been associated as a useful predictor 
of impaired nutritional and functional status, decreased quality of life, increased 
morbidity and shortened survival in tumors such as pancreatic, lung, colorectal, and 
breast cancer.42,61,131,134,138-140 It may also be a predictor for the risk of severe 
complications after surgical procedures in patients with advanced cancer.44 
The problem of the PhA is that most authors generated PhA cutoffs based on 
their study population and those cutoffs are not necessarily transferable to other 
populations. However, reference values from a healthy population offer the possibility 
of assessing individual deviations of a patient in relation to the population average in 
order to help an early identification of patients at risk of impaired functional and 
nutritional status and increased mortality.42 Previous studies have proposed age- and 
sex- specific percentile cutoffs for PhA which have been shown to be clinically useful 
in cancer patients.42 More recently Hui et al.44 defined cutoff PhA values for the 
prognostic of survival in cancer patients as follows: 
2º >PhA< 3º survival time < 3months;  
4º >PhA< 5º survival time between 3 and 6 months;  
PhA ≥ 6º represents a survival time > 6 months. 
Cancer can affect the nutritional status to different degrees of severity. The 
prognostic role of PhA is easier to assess if standardized values are used.129,132 Sick 
individuals, such as cancer patients, are expected to have negative standardized PhA, 
which become increasingly lower with a worsening prognosis.131 According to some 
authors,42,129-131 studying standardized PhA according to sex-, age- and BMI- stratified 
mean reference values enhances its prognostic relevance because individual deviations 
from population norms provide better information than absolute values and only 
malnutrition and inflammation will be identified as significant risk factors. According 
to Norman et al.42 the standardized PhA is the strongest predictor for impaired 
functional and nutritional status and a better indicator of 6 months mortality than are 
malnutrition and disease severity in cancer. They also suggest that the fifth percentile 
of sex-, age-, and BMI- stratified reference values is a suitable and clinically relevant 
indicator of cancer cachexia related symptoms and decreased survival and allows 
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identification of patients at risk who are in particular need of intensified medical and 
nutritional attention. These authors also showed that patients with a PhA below the 5th 
percentile had significantly lower handgrip strength.42  
It is generally agreed that a PhA below 5º means that the person needs medical 
management.139 Gupta et al.134, Hui et al.44 Lee et al.139 demonstrated longer survival 
time in cancer patients with a PhA higher than 4.5º. Selberg et al.136 demonstrated that 
patients with liver cirrhosis that have an abnormally low (<4.4º) and borderline (4.5º 
and 5.4º) PhA have clearly reduced survival times. These studies indicate that PhA is a 
predictor of poor outcome and according to Kyle et al.135 patients with low PhA have 
significantly lower FFM and significantly higher percentage of FM. 
A study conducted by Gupta et al.61 in 259 breast cancer patients concluded that 
those with a PhA ≤ 5.6º had a median survival of 23.1months, while those with a PhA 
> 5.6º had 49.9 months. They also concluded that PhA was a strong predictor of survival 
after controlling for the effects of stage at diagnosis and prior treatment history. The 





2. Relevance of the Study 
 It is known that physical activity is very important in breast cancer patients (BC) 
and breast cancer survivors (BCS) because 74,141 it helps to improve cancer related 
symptoms such as muscular and cardiorespiratory fitness, physical functioning, fatigue, 
psychological well-being, body image, body composition, and health-related 
biomarkers74, improving quality of life.141,142 An important health related component 
of fitness is muscular strength, which has been shown to be positively related to 
cardiorespiratory fitness.143 Although muscular strength has received far less attention 
than cardiorespiratory fitness, recent studies support the hypothesis that low muscular 
strength in adulthood also predicts all-cause mortality, as well as mortality due to 
cardiovascular disease and cancer in healthy and diseased people.33,34,40,41,43,47,86,144-146 
 As the majority of cancer patients do not engage in physical activity 
programms23,  muscle dysfunction, characterized by an impairment in muscle strength 
or muscle composition, may occur.23 Growing evidence suggests that exercise has the 
capacity to moderate and/or reverse muscle dysfunction in patients with cancer. As 
shown by Christensen et al23, early stage BC patients increased muscle strength 25-35% 
after a 17-week resistance training program. 
 A method to assess muscle function is through the handgrip test proven to be 
one of the most reliable, valid, health related to muscular strength. 17,36  
 Recent studies in BCS show that surgical procedure and cancer cachexia, 
defined by severe muscle wasting, systemic inflammation and malnutrition 23,27 were 
causes for the reduction in muscle strength as well as risk factors for all-cause mortality. 
17,23,27 
 Another complication of breast cancer treatment, due to surgery or radiotherapy 
of the axillary area, is lymphedema97 characterized by accumulation of protein-rich 
extracellular fluid resulting from damaged or blocked vessels.  
 A very reliable method to measure this fluid accumulation is through 
bioelectrical impedance (BIA) characterized as a non-invasive, inexpensive, portable 
and easy to use method that gives reliable measurements of body composition.61,93,112,113 
BIA is based on the principle that an electric current flows at different rates through the 
body. Body impedance is an opposition of the conductor to that flow and consists of 
two vectors: resistance R and reactance Xc. 93,106 R is the major opposition to the flow 
of an electric current, related to the amount of water present in the tissues and Xc is the 
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resistive effect produced by tissues interface and cell membranes.61,93,147 The body is 
mostly composed of water with ions, divided into two compartments: intracellular 
(ICW) and extracellular (ECW), and at low frequencies <50kHz current is only 
conducted through extracellular water (ECW and measured impedance is totally 
resistive).93,94,106 It would be important to explore the association of water 
compartments in patients with cancer, as it seems to exist an association between 
cellular hydration and strength, though in other populations.94,113 So far, no study was 
conducted in cancer patients aiming to analyze cellular hydration with strength. 
 As it was mentioned before, at low frequencies ECW is measured but when high 
frequencies are applied, the current penetrates the cell membrane, increasing the 
reactance vector, causing the phase angle (PhA) to open.106 PhA is obtained by 
arctangent of the directly measured reactance-to-resistance ratio.113 It is associated 
positively with most of the nutritional markers and is an indicator of cell integrity and 
water distribution between intra and extracellular spaces.61,113 It is also a prognostic 
marker in several clinical conditions, including cancer,61 as it represents either cell 
death or malnutrition, characterized by changes in cellular membrane integrity. Due to 
this characteristic, PhA is a useful predictor of impaired muscle function.61,113   
 Gupta et al,61 concluded that PhA is a strong predictor for survival in BC 
patients after controlling for the effects of stage at diagnosis and prior treatment history. 
Also, it seems to exist an association between PhA and muscle strength in cancer 
patients44 as both represent measures with prognostic potential.44,112 
This study emerged because there is a need to define prognostic tools easy to 
apply, noninvasive and that are valid for the clinical setting. Studies with these variables 
have been performed in clinical settings but none explored the relationship between 
PhA and water compartments with muscular strength in breast cancer survivors, 
adjusting for potential confounders. 
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3. Objectives  
This study aims to determine if the water compartments and the phase angle are 
predictors of the muscular strength in breast cancer survivors adjusting for habitual 
physical activities, age and time post operation. 
 
4. Methodology 
 In this chapter an overall description of the methods used in this thesis will be 
provided, including study design and sample.  
4.1. Study Design and Sample  
Study Design and Sample Size 
 Forty-one breast cancer survivors were assessed in this observational cross 
sectional study. The measurements of phase angle, muscular strength and water 
compartments were performed at Hospital de São José in partnership with Viva Mulher 
Viva Associação, in a room that was prepared in advance in order to avoid errors. 
Before giving written informed consent to participate, each participant was informed 
about the goals of the study and its benefits.  
All procedures were approved by the Ethics Committee of the Faculty of Human 
Kinetics, University of Lisbon, and were conducted in accordance with the declaration 
of Helsinki for human studies of the World Medical Association.148  
 
Inclusion/Exclusion Criteria 
The inclusion criteria were patients who survived from breast cancer and were 
currently being followed up.  
The exclusion criteria was having performed a recent surgery for removing 
mammary tissue (< 6 months), because according to Gomes et al.17  breast cancer 
survivors show changes in body composition and handgrip strength 6 months after 
surgery. 
 We assured that the participants recruited were not involved in other studies or 
under any dependent relationship with the investigators of the study.  
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4.2. Body composition measurements 
 The protocol involved preparation/instructions to subjects, anthropometrics, 
international physical activity questionnaire, measurement of handgrip and 
bioelectrical impedance. Each session lasted approximately 30 minutes. 
 4.2.1. Preparation 
 Each participant was instructed to do overnight fast before coming for a 
morning visit at Hospital São José and to wear minimal clothing. They were further 
asked to remove all objects that could interfere with bioelectrical impedance 
assessment. The following measurements were conducted: 
 4.2.2. Anthropometry 
Measurement of Body Mass and Stature using Anthropometry 
The participants weight and height were measured using a stadiometer with a 
scale incorporated (SECA, Hamburg, Germany), respecting standardized procedures. 
The measurement was taken after subject removed the shoes and using minimal clothes. 
Weight and height were measured to the nearest 0.01kg and 0.1cm, respectively.  
Body mass index (BMI) was calculated as body mass (kg) divided by the square 
of the stature (m). 
 
Measurement of waist and hip circumferences  
Waist circumference was measured according to the United States National 
Institute of Health protocol, at the top of the iliac crest.67 Hip circumference 
measurement was taken at the widest portion of the buttocks.66,149 Both measurements 
were taken with the measuring tape parallel to the floor and snugged around the body, 
without constricting it. The participants were in the erect position and weight 
distributed evenly. Waist-to-hip ratio (WHR) was calculated as waist circumference 
divided by hip circumference.62,149 
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4.3. Bioelectrical Impedance Spectroscopy (BIS) 
 The present study used BIS analyzer model 4200B Xitron Technologies (San 
Diego, CA, USA). 
 Anthropometric variables, gender and age of individuals were inserted into the 
interface of BIS software and only then the examination was initiated. 
A few requirements prior the test were taken into consideration in order to 
guarantee the validity, reproducibility and precision of the measurement: position of 
the body, length of time in supine position before measurement, correct stature 
measurement, skin preparation with alcohol before electrode placement, electrode 
position, hydration status, menstrual cycle, consumption of food, beverages and 
diuretic drinks before test, ambient air and skin temperature, recent physical activity, 
the use of metals and conductance of the examination table.  
Participants adopted a supine position with their arms and legs abducted at an 
angle of 45º. After cleaning the skin with alcohol, four electrodes were placed on the 
dorsal surfaces of the right hand and right foot. The source electrodes were placed on 
the hand, in the middle of the dorsal surface proximal to the metacarpal-phalangeal 
joint, and on the foot, in the middle of the dorsal surface proximal to the metatarsal-
phalangeal joint. The detector electrodes were placed on the wrist at the midline 
between the distal prominences of the radius and ulna and in the ankle joint at the line 
between the malleoli. The source and detector electrodes must be placed with a 5cm 
distance between each other. After placement of electrodes we connected the black 
cable to the distal surface and the red cable to the proximal surface. The alternating 
current is passed through the outer pair of electrodes, while the voltage drop across the 
body is measured using the inner pair of electrodes.  
Figure 3: Example of how the electrodes must be placed in the right hand and foot 
for BIS assessment. 
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The measurements were performed 10 minutes after the participants have been 
lying down and whole body resistance (R) and reactance (Xc) was determined from a 
5KHz to 1MHz spectrum, from which impedance (Z) is derived, according to the Cole-
Cole cell suspension model.108 This procedure derives a theoretical impedance at zero 
and infinity frequencies, based on a non-linear curve fitting from the measured 
resistance and reactance. 
4.4. Water Compartments 
The R values at the ideal measurement frequencies are predicted using Cole-
Cole plot, with R0 representing the R of the ECW and R∞ representing the R of intra- 
and extracellular fluid (TBW).110  
The BIS software is programmed to perform biophysical modeling on the 
impedance data according to Cole-Cole cell suspension model108 to generate Cole 
model terms: Re – resistance associated with the ECW; Ri – resistance associated with 
the ICW; Cm – cell membrane capacitance; and exponent α. The ECW and ICW 
volumes are predicted from the modeled Re and Ri using equations formulated by the 
Hanai mixture model117. The TBW is calculated as the sum of ECW and ICW.  
 Gudivaka et al.107 found that the Cole-Cole model accurately predicted changes 
in TBW, ECW and ICW in diseased populations, where the ratio ECW to TBW is 
altered.110 
4.5. Phase Angle (PhA) 
The relationship between capacitance and R is interesting because it reflects 
different electrical properties of tissues that are affected in various ways by disease, 
nutritional status, and hydration status.  
When R and capacitance are plotted graphically after standardizing for height, 
sex, race, etc., different disease/conditions appear to form different clusters. The PhA, 
which is one measure of the relationship described above, and other interrelated indices, 
including R0/R∞, has been used to predict clinical outcome
110 since is one of the best 
indicators of cell membrane function related to the ratio of ECW and ICW. 
 Capacitance causes a phase shift quantified geometrically as the arctangent of 
the ratio of reactance to resistance, or phase angle. The phase angle was calculated using 
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the following equation:  
Phase Angle (degrees) = (Resistance/Reactance)*(180/π). 
The most common frequency to extrapolate the phase angle is 50kHz since the 
current passes through both intra- and extracellular fluids.110 
4.6. Handgrip Strength 
Measurement of forearm maximal strength 
Forearm maximal strength will be determined using a handgrip dynamometer 
(Jamar, Sammons Preston, Inc., Bolingbrook, IL, USA) with visual feedback. The 
assessment was made sitting in a straight-backed chair with the feet flat on the floor, 
shoulder adducted and neutrally rotated, elbow flexed at 90º with forearm in a neutral 
position, according to the methodology purposed by the American Society of Hand 
Therapists (ASHT).48 Dynamometer was adjusted to each subject’s hand with each trial 
lasting approximately 3 seconds. The best of 3 maximal trials was used for data 
analysis. Measurements of right and left side were taken in all the subjects and 
dominant side was noted. The same adjustment of the dynamometer was used for all 
tests for each subject.  
This method was developed for the use with the Jamar dynamometer.49 Most of 
the studies follow the ASHT protocol in an attempt to control known risk of errors.48 
4.7. Physical Activity  
Physical activity was evaluated with short form of International Physical 
Activity Questionnaire (IPAQ). The IPAQ short form is a seven-item measure of four 
domains of activity: vigorous-intensity physical activity; moderate-intensity physical 
activity; walking and sitting. Participants reported frequency (during the last seven 
days) and duration of physical activity (minutes/hours usually spent on one of those 
days). Participants also reported the total time they’ve spent sitting on a week day 
during the last seven days. Physical activity was calculated as the summation of the 
days, hours and minutes of vigorous-intensity and moderate-intensity physical activity, 
presented in minutes. 
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4.8. Statistical Analysis 
 Sample size was calculated considering a moderate (>0.15) Cohen’s ƒ2 effect 
size (which is appropriate for calculating the effect size within a multiple regression 
model in which the independent variable of interest and the dependent variable are both 
continuous) with a type I error of 10%, power 80% and 4 predictors (the independent 
variable: phase angle or ICW or ECW and three confounding variables: age, time post-
operation, moderate-to-vigorous physical activity) a total of 32 participants was 
required. To assure that equipment failure or any missing variable would not affect the 
calculated effect size we over-sized the required sample by 25%, and therefore, ~40 
participants were recruited. 
Statistical analysis was performed using IBM SPSS Statistics for Mac OS 
version 22.0, 2010 (SPSS Inc., IBM Company, Chicago IL, USA). The statistical 
significance was set as p < 0.1, specifically for the variables that were tested as 
independent predictors of muscular strength. 
 Descriptive statistics (means ± standard deviation) were performed for all 
outcome measurements.  
 Bivariate correlations were conducted in a preliminary analysis. 
 A potential confounding variable in BCS is edema of the distal extremities, 
which may result from lymphedema, and will affect impedance measurements.93  
 In order to examine whether lymphedema interact with the relationship between 
impedance variables and strength, Univariate General Linear Model test was conducted 
to test if the lymphedema by each bioimpedance variables was significant. If this is 
nonsignificant (p<0.05) the sample will be further analyzed as a whole.  
Multiple regression model was used to determine if our dependent variable Y 
(HGR, HGL, HGdom) was predicted by one or more of the independent variables X 
(BIS variables, moderate-vigorous physical activity (MVPA), age and time post 
operation (TPO)). As expressed in the following equation: 
YHG = β0 + β1XBis variables + β2XMVPA + β3Xage + β4XTPO + ε 
where β0, β1,.. βk are the regression coefficients and ε the error. 
 The coefficient of determination r2 was also determined for all outcome 
variables. This parameter measures the quality of the adjustment of the model and 
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represents the variability of the dependent variable that is explained by the regression 







In this chapter it will be presented the main results of this study. 
5.1. Characteristics of the Sample 
In table 1 means and standard deviations regarding the characteristics of the 
sample (n=41) such as age, anthropometric (body mass, stature, BMI, waist 
circumference, hip circumference, WHR), BIS (PhA, ECF, ICF, FFM), handgrip 
(HGR, HGL, HGdom) and physical activity (MVPA) measurements are summarized.  
Univariate general linear test was performed to understand if phase angle was 
explanatory of the handgrip regardless of a participant having or not lymphedema. 
Because there was no interaction found, the sample was analyzed as a whole. 
5.2. Preliminary Tests 
Bivariate correlations were performed to observe if there was any association 
between phase angle, and other BIS related variables with handgrip measurements. 
Direct associations were observed between phase angle and handgrip measured 
on the right side. No associations were found with regard to handgrip measured on the 
left side and dominant side. 
Since the analysis of the interaction term lymphedema by each bioimpedance 
variables was nonsignificant (p>0.05) in explaining muscular strength, the whole 
sample was used to test the predictive power of phase angle in explaining muscular 
strength. 
5.3. Multiple Regression Analysis 
 Multiple regression analysis was performed controlling PhA, step by step, for, 
age, MVPA and time post operation (TPO). As presented in table 2 and 3 the phase 
angle emerged as an explanatory variable of the handgrip measured on the right side, 
independently of MVPA, age and TPO.  
 Linear regression analysis, table 2, showed that phase angle explained 22% 
(r2=0.216) of the variance of the handgrip.  
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Chart 1 represents the association between the dependent variable (handgrip) 
and the independent variable (phase angle). 
 
Table 1: Participants characteristics 
Variables Mean ± Std. Deviation 
Age (yrs) 54.6 ± 9.2 
Body Mass (kg) 68.0 ± 11.7 
Stature (cm) 159.9 ± 6.7 
BMI (kg/m2) 26.6 ± 4.6 
Waist Circumference (cm) 87.1 ± 10.9 
Hip Circumference (cm) 100.3 ± 8.9 
WHR  0.9 ± 0.1 
PhA (º) 5.5 ± 0.7 
ECF (L) 13.9 ± 1.7 
ICF (L) 16.1 ± 3.0 
FFM (kg) 39.9 ± 6.3 
HGR (kg) 24.9 ± 5.5 
HGL (kg) 22.0 ± 5.9 
MVPA (min/week) 99.4 ± 118.7 
Abbreviations: BMI: body mass index; WHR: waist hip ratio; BIS: bioelectrical impedance analysis; 
PhA: phase angle; ECF: extracellular fluid; ICF: intracellular fluid; FFM: fat free mass; HGR: handgrip 






Table 2: Predictive power of phase angle in explaining muscular strength 






1 0.47a 0.22 0.20 4.90 
2 0.59b 0.35 0.31 4.53 
3 0.59c 0.35 0.30 4.57 
4 0.61d 0.37 0.30 4.58 
a. Preditors: (Constant), Phase angle 
b. Preditors: (Constant), Phase angle, age 
c. Preditors: (Constant), Phase angle, age, moderate to vigorous physical activity (MVPA) 
d. Preditors: (Constant),  Phase angle, age, MVPA, time post operation 
* coefficient of correlation 
#coefficient of determination 
 






















Handgrip right side (kg)
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 B Std. Error Beta   
(Constant) 3.51 6.57    0.60 
PhA (º) 3.91 1.19 0.47  0.00 
(Constant) 22.60 9.23    0.02 
PhA (º) 2.71 1.19 0.32  0.03 
Age -0.23 0.08 -0.39  0.01 
(Constant) 24.39 9.77    0.02 
PhA (º) 2.48 1.26 0.30  0.06 
Age -0.25 0.09 -0.42  0.01 
MVPA (min/week) 0.00 0.01 0.09  0.55 
(Constant) 25.71 9.90    0.01 
PhA (º) 2.27 1.28 0.27  0.09 
Age -0.26 0.09 -0.45  0.01 
MVPA (min/week) 0.00 0.01 0.06  0.66 
TPO (month) 0.02 0.02 0.13  0.37 
Abreviations: PhA: phase angle; MVPA: moderate-to-vigorous physical activity; TPO: time post 





We found that the phase angle explained 22% of the variability in muscular 
strength and remained in the model even after adjusting for age, habitual physical 
activity and time post operation. However, no association was found between water 
compartments and muscular strength. 
 As mentioned before, PhA is one of the best indicators of cell membrane 
function related to R (hydration) and Xc (membrane area & integrity), which are both 
associated with handgrip strength. 
Phase angle represents a novel marker of cellular function. A higher PhA 
represents good cell integrity and a low PhA represents cell death or decreased cell 
integrity.61  
In comparison to healthy subjects, a low phase angle frequently occurs in sick 
patients correlating with disease severity.130 It has consequently been shown to be 
predictive of impaired prognosis (mortality, disease progression, incidence of 
postoperative complications, length of hospital stay) in pancreatic, colorectal, breast 
and lung cancer, as well as in HIV/AIDS,  liver cirrhosis, renal insufficiency on 
peritoneal- or haemo-dialysis, amyotrophic lateral sclerosis, systemic sclerosis, 
bacteraemia/sepsis and surgical patients.130,131  
However, despite its prognostic value, there is still the need to define valid cut-
off values in order to use it as clinical indicator for disease related malnutrition in 
various disease settings.130 The problem with PhA is that most authors generate PhA 
cut-offs based on their study population which makes them specific and non 
transferable to other populations.42 Gupta et al.61, Hui et al.44 and Lee et al.139 
demonstrated longer survival time in cancer patients with a PhA higher than 5.6º. In the 
current study, the PhA mean value (5.48 ± 0.65) can be of concern if we follow the cut-
off values presented in the studies mentioned before. Gupta et al61 went further and 
established that patients with BC that had a PhA < 5.6º had a median survival of 23.1 
months while those with a PhA > 5.6º had a median survival of 49.9 months. However, 
an important note must be considered, all of this studies were performed in patients 
with cancer. 
Phase angle is also one of the best indicators of cell membrane function related 
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to the ratio between extracellular and intracellular water. Significant alterations in body 
fluid hydration, fluid distribution and differences in the ECW/BCM ratio caused by 
medical condition can affect impedance measurements and are probably associated 
with changes in the PhA.136 According to Schwenk et at137 in systemic illness a low 
PhA corresponds to a high ECW-ICW ratio due to the ECW expansion and loss of 
ICW. One of the most significant confounding variable is edema of the distal 
extremities which may result in lymphedema.93 In the current study, to understand the 
significance of this variable a univariate general linear model was performed, showing 
that lymphedema was not an interactive factor. Edema represents an accumulation of 
protein-rich extracellular fluid resulting from damaged or blocked vessels, leading to 
swelling.99 Any edema, whatever the underlying cause, is due to an imbalance between 
capillary filtration and lymph drainage. Lymphedema strictly occurs when swelling is 
due to a failure of lymph drainage in circumstances in which capillary filtration is not 
increased150 due to node removal or adjuvant treatment such as radiation.97 
Because of the existing link between lymphedema and body fluids we compared 
if ECW would be higher in the group of women with lymphedema (N=5), using Mann-
Whitney test. Women in this sample that showed lymphedema presented higher ECW 
values compared to those without lymphedema. This findings are in line with what has 
been discovered in other studies,99,100 that lymphedema is characterized for an 
expansion of ECW. 
 In this study, there was no association between ECW and ICW and the handgrip 
strength. Possible causes may be due to the fact that in disease, the ECW/BCM ratio is 
altered. According to a study conducted in athletes, a 3-4% reduction in hydration leads 
to a 2% reduction in muscular strength.94 However, to our knowledge, there are no 
studies conducted in BCS relating hydration status with handgrip strength. According 
to Haussinger et al.151 a cell swelling theory states that cellular shrinkage, leads to 
catabolism. Because in systemic illness, there is a decrease in ICW, our goal was to see 
if there was an association between this cell shrinkage and the lack of strength in the 
population in study. According to Earthman et al.118 it was observed in HIV patients 
that a loss of ICW, which reflects BCM loss, can cause a decrease in physical strength 
and immune function. 
So far, investigations with water compartments in breast cancer patients have 
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been related to associations between lymphedema and ECW. One study conducted by 
Gomes et al.17 reported that handgrip strength was the same regardless the presence or 
absence of lymphedema (ECW). Further studies are needed to understand if a decrease 
in muscle strength of BCS is related to a decrease in ICW. 
Loss of function and muscle strength occurs with both disease and malnutrition 
and it is of major clinical significance. 
Data from the current study suggest that phase angle is a predictor of strength 
assessed by handgrip measured on the right side (Table 3). In a study conducted by 
Norman et al.112, significant association between PhA and handgrip strength were also 
found. Another study44 conducted in advanced cancer patients found that phase angle 
was a significant predictor of survival and that lower handgrip strength demonstrated a 
trend toward shorter survival.  
This test is the most reliable, valid and easy to perform within the oncologic 
setting. Its ability to characterize overall strength has been given the possibility to 
predict postoperative complications, functional limitations, disabilities and mortality. 
It has been used as a health-related quality of life in BCS.  
A systematic review conducted by Neil-Sztramko et al.18 pooled grip strength 
data from 26 studies in BC population and reported that the mean value was 22.8 kg 
(95% CI 20.6 to 25.1) in women off treatment. Bohannon et al.52 presents age, gender 
and side specific reference values for handgrip strength, measured with Jamar and in 
accordance with the ASHT protocol, derived from a meta-analysis of multinational 
data. Individual patients whose grip strength is less than the lower limit of the 
confidence intervals can be considered to be impaired. 
In the present study, mean value of the handgrip measured on the right side was 
24.90 kg, a value below what is expected based on the mean age of this sample. 
These values demonstrate the need to monitor physical function after treatment 
(as well as during treatment) in order to help health professionals to identify declines 
and improve functional outcomes.   
Physical activity has been used as a therapeutic aid in the treatment of various 
pathophysiological conditions.19 It has been found, in healthy populations, decreases in 
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muscular endurance after only 2 weeks of physical inactivity. In disease, physical 
inactivity results in more exacerbated reductions.  
Findings from a study performed by Schneider et al19 suggest that moderate-
intensity exercise can provide a sufficient physiological stimulus to improve muscular 
performance in cancer survivors. 
One of the findings of the present study was that most of BCS do not engage in 
enough physical activity programs (MVPA 99.39 ± 118.67 min) not meeting the 
minimal recommendations for physical activity (150 minutes). This can be one of the 
causes, besides cancer treatment itself, responsible for the loss of muscular strength.  
Our findings are in agreement with a study conducted by Holick et al78 where it was 
reported that up to 70% of BCS did not meet recommendations of 150 minutes per 
week of moderate to vigorous intensity PA (e.g. brisk walking, jogging, swimming). 
According to Bosetti et al152, around 50% of patients with cancer have an 
existing chronic condition and are at increased risk of developing new comorbidities 
such as heart failure, diabetes, osteoporosis and others, during the survivorship period.  
This and the fact that most of the BCS do not engage in enough physical activity leads 
to many other factors such as an increase in body mass, waist circumference and WHR. 
This variables are associated with several outcomes that can lead to mortality and BC 
recurrence.63,66,76,153 
According to some authors, when the BMI is over 25 that person is at increased 
risk of developing health problems due to abnormal or excessive fat accumulation.68,71 
In the present study, among the 41 women assessed, 26 presented a BMI > 25 kg/m2, 
16 have a WC > 88cm and 25 have a WHR > 0.85. World Health Organization cutoff 
points of waist circumference and WHR for substantial increased risk of metabolic 
complications in women are > 88 cm and  0.85, respectively.69 
BMI is a number based on a person’s weight and height. The higher the number, 
the more body fat a person has. WC and WHR are variables that correlate with central 
obesity and are also associated with weight gain,62,68 specifically fat distribution in the 
abdominal area.  
 61 
As so, overweight and obesity are associated with low levels of PA which can 
lead to lower muscle strength.154 However, in our study, there was no association 


















 Despite the encouraging findings of this study, some limitations must be 
addressed. 
 Firstly, given the global scale of this disease, our sample (n=41) is small, which 
does not allow for a generalization of the results. Also, the power to detect any 
association may be compromised with this current sample size. 
Secondly, the sample is not equitable in terms of age. The youngest participant 
was 36 years old and the oldest was 76 years old, which influences body composition 
parameters assessed from BIA, such as PhA, as the older the person, the lower the PhA 
(due to a reduction in reactance which parallels the loss of muscle mass).110,130 
Nevertheless, we adjusted our analysis for age as aconfounder variable between the 
association of PhA with strength. 
 Finally, given the cross sectional design this study does not allow a casual effect 
relationship. 














Our findings indicate that regardless of age, MVPA and TPO, phase angle was 
a significant predictor of muscular strength as assessed by the handgrip test. However, 
water compartments were not associated with muscular strength. 
  
9. Future work 
Although there was no relationship found between handgrip and water 
compartments, namely ICW, in our population, future studies should explore possible 
associations of cell hydration and strength.  
Also, performing a longitudinal study must be of interest in order to understand 
the behavior of these variables (phase angle, handgrip, ICW and ECW) over time. 
 It would also be newsworthy to conduct a study comparing BIA related 
parameters and muscular strength between breast cancer patients (in different stages of 
BC) and survivors, adjusting for counfonders, since there is no study, to date, that has 
shown the behavior of these variables according to the stage of the disease, including 
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